Results 31 to 40 of about 10,485 (198)
Global Spine JournalStudy Design Retrospective Cohort Study. Objective The primary objective of this study is to evaluate the efficacy of early administration of Teriparatide in preventing the necessity of surgical intervention in individuals with osteoporotic vertebral ...
Vishnu Vikraman Nair MBBS, MS +1 more
doaj +1 more source
Case Reports in Endocrinology, 2014 Introduction. Bone disease is a common complication of cystic fibrosis (CF). To date, there have been no reports on the effectiveness of teriparatide, recombinant human parathyroid hormone, to treat CF-related bone disease. Case Presentation.
Oranan Siwamogsatham +2 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.This original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
Marea O'Donnell +7 more
wiley +1 more source
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
, 2008 Claudia Gagnon, Vivien Li, Peter R EbelingDepartment of Medicine, University of Melbourne, Melbourne, AustraliaAbstract: As the population ages, the burden of osteoporosis in men is expected to rise.
Claudia Gagnon +5 more
core +1 more source
Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
Clinical Pharmacology &Therapeutics, EarlyView.Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu +5 more
wiley +1 more source
, 2014 Objective: To evaluate effects of teriparatide therapy on bone mineral density (BMD), biochemical parameters, back pain, and quality of life in patients with severe osteoporosis, who had long-term bisphosphonate treatment. Materials and Methods: Fifteen
Alev Çevikol +5 more
core +1 more source
Treatment of osteoporosis with teriparatide
, 2023 The aim of this study was to investigate the characteristics of postmenopausal women prescribed with teriparatide in Slovenia, during the first decade after its approval, and the predictors of bone mineral density (BMD) improvement with treatment.
Kocjan, Tomaž +7 more
core +1 more source
Mind the Gap: Predictors of Osteoporosis Treatment Following Fragility Fracture in Parkinsonism
Movement Disorders Clinical Practice, EarlyView.Abstract Background Fracture risk is increased in Parkinson's yet this risk is often not addressed. Objectives Our objective was to study the extent to which osteoporosis was treated, and predictors of treatment in a large representative cohort with parkinsonism.
Katie C. Naylor +2 more
wiley +1 more source
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups [PDF]
, 2021 Teriparatide has proven effective in reducing both vertebral and non-vertebral fractures in clinical trials of post-menopausal and glucocorticoid-induced osteoporosis.
Hauser, Barbara +5 more
core +1 more source
Staging concept for aging management: Definition, mechanism, and coping strategies
VIEW, EarlyView.We divided the overall aging stage into “pre‐aging”, “aging compensation”, and “aging disability”. For each stage, we delineate the clinical presentations, biological phenomena, theoretical underpinnings, and key management priorities. Abstract Aging, as a gradual and largely irreversible biological process, characterized by declining organismal ...
Zhonghan Wang +6 more
wiley +1 more source